Skip to main content

View full-text article in PMC

. 2012 Oct;85(1018):1376–1384. doi: 10.1259/bjr/19932596

Table 2. Hypervascularity before and after contrast agent administration.

Entity	Diameter						Total
	1.0–2.0 cm		2.1–3.0 cm		3.1–5.0 cm		Total
	Before	After	Before	After	Before	After	Before	After
HCC (n=116)	16/39 (41.0%)^a,b	34/39 (87.2%)	23/34 (67.6%)^a	33/34 (97.1%)	33/43 (76.7%)^b	43/43 (100.0%)	72/116 (62.1%)	110/116 (94.8%)
MRN (n=26)	3/24 (12.5%)	1/24 (4.2%)	0/2	0/2	0/0	0/0	3/26 (11.5%)	1/26 (3.8%)
HGDN (n=5)	1/2 (50.0%)	2/2 (100.0%)	0/1	1/1 (100.0%)	2/2 (100.0%)	0/2	3/5 (60.0%)	3/5 (60.0%)

HCC, hepatocellular carcinoma; HGDN, high grade dysplastic nodule; MRN, macroregenerative nodule.

The values with the same superscript are compared:

^ap =0.023.

^bp =0.001.